Deutsche Bank AG Reduces Stock Holdings in Integer Holdings Corporation $ITGR

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Deutsche Bank AG lessened its holdings in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 9.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,716 shares of the medical equipment provider's stock after selling 2,665 shares during the period. Deutsche Bank AG owned 0.08% of Integer worth $3,153,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the stock. Vaughan Nelson Investment Management L.P. acquired a new position in Integer in the 1st quarter valued at about $33,337,000. Capital Research Global Investors lifted its holdings in Integer by 16.0% in the fourth quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock valued at $186,960,000 after acquiring an additional 194,895 shares during the last quarter. GAMMA Investing LLC grew its position in Integer by 8,697.6% in the first quarter. GAMMA Investing LLC now owns 78,123 shares of the medical equipment provider's stock worth $92,190,000 after acquiring an additional 77,235 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Integer in the fourth quarter worth approximately $7,889,000. Finally, Northern Trust Corp increased its stake in Integer by 14.2% during the fourth quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider's stock worth $55,974,000 after acquiring an additional 52,556 shares during the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ITGR has been the topic of several recent analyst reports. Truist Financial decreased their price target on Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research note on Friday, July 25th. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and upped their target price for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. Benchmark lowered their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Wells Fargo & Company cut their target price on Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research report on Friday, July 25th. Finally, Raymond James Financial lowered their target price on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a report on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $140.25.

Integer Stock Performance

ITGR stock traded up $3.8450 during trading on Friday, hitting $110.6750. The company had a trading volume of 103,949 shares, compared to its average volume of 478,867. The firm has a 50-day moving average price of $113.91 and a 200-day moving average price of $119.40. The company has a quick ratio of 2.18, a current ratio of 3.41 and a debt-to-equity ratio of 0.72. The firm has a market cap of $3.88 billion, a PE ratio of 48.62, a price-to-earnings-growth ratio of 0.85 and a beta of 1.02. Integer Holdings Corporation has a 1-year low of $104.93 and a 1-year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). The company had revenue of $476.00 million during the quarter, compared to analyst estimates of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. The company's revenue for the quarter was up 11.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Insider Activity at Integer

In related news, Director Donald J. Spence sold 14,739 shares of Integer stock in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total value of $1,774,280.82. Following the sale, the director directly owned 18,781 shares in the company, valued at $2,260,856.78. The trade was a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director owned 22,170 shares of the company's stock, valued at $2,672,815.20. This represents a 28.23% decrease in their position. The disclosure for this sale can be found here. 2.16% of the stock is owned by company insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.